The recent surge in Human Metapneumovirus (HMPV) infections in China has captured global attention, urging caution among individuals worldwide.

In China, health professionals are advising the public to refrain from attempting to address this virus on their own, highlighting the importance of professional medical intervention.

Reports from Chinese state media highlight that pulmonologists are cautioning against the use of over-the-counter antiviral and antibacterial medications for treating this infection.

In a recently published interview, experts emphasized that as of now, clinical studies have not identified any vaccines or medications specifically effective against HMPV.

Patients are advised to consult medical professionals for guidance rather than self-medicating with standard antiviral or antibacterial drugs, which may not be appropriate for HMPV treatment.

Doctors have observed that the virus tends to be self-limiting in nature. Typically, symptoms resolve within a week, with mild cases recovering within one to two weeks.

The incubation period after infection is approximately three to six days, with symptoms resembling those of the flu, as noted in official statements to the public.